DOI QR코드

DOI QR Code

Ciga-X inhibits nicotine-induced human lung fibroblasts cytotoxicity and craving for cigarettes

  • Published : 2002.08.30

Abstract

Cigarette smoking contributes to lung cancer, cardiovascular diseases, oral diseases, etc. In desire to reduce their risk of disease, many cigarette smokers have tried to quit smoking. Sensory aspects of cigarette smoke are important for providing smoking satisfaction. Previously it was reported that citric acid aerosol significantly reduced craving for cigarettes and enhances smoking reduction and cessation. In this study, we tested whether a newly combined product Ciga-X, an aerosol for cessation aid, had toxicity in human embryonic lung fibroblast (MRC-9). The inhibitory effect of Ciga-X on cytotoxicity induced by cigarette smoke extract (CSE) or nicotine was examined in MRC-9, and craving for cigarettes and smorkers satisfaction after using Ciga-X was estimated. Ciga-X did not affect cell viability and had no toxicity in MRC-9. Ciga-X significantly inhibited not only CSE-induced cytotoxicity but also nicotine-induced cytotoxicity in MRC-9. One hundred and forty smokers rated the satisfaction for Ciga-X aerosol and craving reduction for cigarettes after using Ciga-X. The percentage of over 5 rating was 71.0% and 50.0% of subjects in satisfaction test for Ciga-X compared to their own brand and in craving reduction for cigarette, respectively. Besides, craving reduction for cigarette was highly correlated with the duration of smoking. Subjects have smoked under 10 years were more reduced in craving for cigarettes after using Ciga-X as compared to over 10 years (p=0.049). These results suggest that Ciga-X may be effective in promoting smoking abstinence with the reduction of CSE- or nicotine-induced human lung fibroblasts cytotoxicity.

Keywords

References

  1. Behm FM, Schur C, Levin ED, Tashkin DP, Rose JE. (1993) Clinical evaluation of a citric acid inhaler for smoking cessation. Drug Alcohol Depend. 31, 131-138. https://doi.org/10.1016/0376-8716(93)90065-X
  2. Benowitz NL. (1988) Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. N. Eng. J. Med. 319, 1318-1330. https://doi.org/10.1056/NEJM198811173192005
  3. Bobrie G, Battaglia C, Loufrani E, Menard J. (1993) Drug aid to tabacco withdrawal. Rev. Prat. 43, 1238-1244.
  4. Burki NK, Davenport PW, Safdar F, Zechman FW. (1983) The effects of airway anesthesia on magnitude estimation of added inspiratory resistive and elastic loads. Am. Rev. Respir. Dis. 127, 2-4. https://doi.org/10.1164/arrd.1983.127.1.2
  5. Hajek P, West R, Foulds J, Nilsson F, Burrows S, Meadow A. (1999) Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch. Intern. Med. 159, 2033-2036. https://doi.org/10.1001/archinte.159.17.2033
  6. Hays JT, Dale LC, Hurt RD, Croghan IT. (1998) Trends in smoking-related diseases. Why smoking cessation is still the best medicine. Postgrad. Med. 104, 56-71. https://doi.org/10.3810/pgm.1998.12.389
  7. Hoffmann D, Djordjevic MV, Hoffmann I. (1997) The changing cigarette. Prevent. Med. 26, 427-434. https://doi.org/10.1006/pmed.1997.0183
  8. Hughes JR, Hatsukami DK, Pickens RW, Krahn D, Malin S, Luknic A. (1984) Effect of nicotine on the tabacco withdrawal syndrome. Psychopharmacol. 83, 82-87. https://doi.org/10.1007/BF00427428
  9. Kim MS, Lim WK, Cha JG, An NH, Yoo SJ, Park JH, Kim HM, Lee YM. (2001) The activation of PI3-K and PKC $\zeta$ in PMA-induced differentiation of HL-60 cells. Cancer Lett. 171, 79-85. https://doi.org/10.1016/S0304-3835(01)00505-5
  10. Levin ED, Rose JE, Behm F. (1990) Development of a citric acid aerosol as a smoking cessation aid. Drug Alcohol Depend. 25, 273-279. https://doi.org/10.1016/0376-8716(90)90152-5
  11. Mayhan WG, Sharpe GM. (1996) Effect of cigarette smoke extract on anteriolar dilatation in vivo. J. Appl. Physiol. 81, 1996-2003. https://doi.org/10.1152/jappl.1996.81.5.1996
  12. Mosman T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Method 65, 55-63. https://doi.org/10.1016/0022-1759(83)90303-4
  13. Ouyang Y, Virasch N, Hao P, Aubrey MT, Mukerjee N, Bierer BE, Freed BM. (2000) Suppression of human IL-$1\beta$, IL-2, IFN-$\gamma$, and TNF-$\alpha$ production by cigarette smoke extracts. J. Allergy Clin. Immunol. 106, 280-287. https://doi.org/10.1067/mai.2000.107751
  14. Rodgman A, Smith CJ, Perfetti TA. (2000) The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components. Hum. Exp. Toxicol. 19, 573-595. https://doi.org/10.1191/096032700701546514
  15. Rose JE, Behm FM, Westman EC, Johnson M. (2000) Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacol. Biochem. Behav. 67, 71-81. https://doi.org/10.1016/S0091-3057(00)00301-4
  16. Rose JE. (1996) Nicotine addiction and treatment. Annu. Rev. Med. 47, 493-507. https://doi.org/10.1146/annurev.med.47.1.493
  17. Rose JE. (1988) The role of upper airway stimulation in smoking. In: Nicotine replacement: A critical evaluation, edited by Pomerleau OF, Pomerleau CS, p. 95-106, Alan R. Liss, Inc., New York.
  18. Rose JE, Hickman GS. (1987) Citric acid aerosol as a potential smoking cessation aid. Chest 92, 1005-1008. https://doi.org/10.1378/chest.92.6.1005
  19. Rose JE, Tashkin DP, Ertle A, Zinser MC, Lafer R. (1985) Sensory blockade of smoking satisfaction. Pharmacol. Biochem. Behav. 23, 289-293. https://doi.org/10.1016/0091-3057(85)90572-6
  20. Sommese T, Patterson JC, (1995) Acute effects of cigarette smoking withdrawal: a review of the literature. Aviat. Space. Environ. Med. 66, 164-167.
  21. Waldum HL, Nilsen OG, Nilsen T, Rorvik H, Syversen U, Sandvik AK, Haugen OA, Torp SH, Brenna E. (1996) Long-tern effects of inhaled nicotine. Life Sci. 58, 1339-1346. https://doi.org/10.1016/0024-3205(96)00100-2
  22. Wang H, Liu X, Umino T, Skold CM, Zhu Y, Kohyama T, Spurzem JR, Romberger DJ, Rennard SI. (2001) Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am. J. Respir. Cell Mol. Biol. 25, 772-779. https://doi.org/10.1165/ajrcmb.25.6.4458
  23. West R, Shiffman S. (2001) Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review. Psychopharmacol. 155, 115-122. https://doi.org/10.1007/s002130100712
  24. Westman EC, Behm FM, Rose JE. (1996) Airway sensory replacement as a treatment for smoking cessation. Drug. Dev. Res. 38, 257-262. https://doi.org/10.1002/(SICI)1098-2299(199607/08)38:3/4<257::AID-DDR14>3.0.CO;2-W
  25. Zevin S, Gourlay SG, Benowitz LL. (1998) Clinical pharmacology of nicotine. Clin. Dermatol. 16, 557-564. https://doi.org/10.1016/S0738-081X(98)00038-8